The growing interest in successful weight management has led to considerable exploration into novel treatments. Currently, Retatrutide, a twin-action hormone and glucagon-like peptide-1 (GLP-1) receptor activator , has exhibited positive results in medical trials, indicating potential for significant weight decrease. As a result , many individuals